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To determine the effects of chronic myocardial infarction
on beta-adrenergic properties of canine myocardium,
the hearts of nine mongrel dogs were studied 3 weeks
after acute myocardial infarction. Infarction was produced
by ligating the left anterior descending coronary artery
in five dogs and the circumflex artery in four dogs. The
heart was divided into normal and infarct zones (either
anterior or posterior, depending on the vessel ligated)
and marginal zones (septal and lateral), each zone being
subdivided into epicardial and endocardial portions.
Myocardial blood flow (microsphere technique) was
markedly reduced in the infarct zone.
In eight endocardial infarct samples after left anterior
descending ligation, the maximal number (± SD) of
binding sites assessed by 125I-iodocyanopindolol was 3.9
± 1.9 pmol/mg deoxyribonucleic acid (DNA) and was
reduced from normal endocardial values (9.7 ± 9.4
pmol/mg DNA, p < 0.05). The dissociationconstant (Ket),
which is a measure of the affinity of the iodinated an-
tagonist for the receptor, did not differ (304 ± 222 ver-
sus 338 ± 219 pM, p = NS). In the epicardium, the
maximal number of beta-adrenergic receptors was also
reduced (p < 0.05), without a change in Ket. In the lateral
and septal zones neither the maximal number of binding
Primarily on the basis of two large clinical trials (I ,2), long-
term beta-adrenergic blockade has been recommended to
prevent recurrent infarction and sudden death after acute
myocardial infarction. The mechanism of action of beta-
adrenergic blockade under these circumstances is unknown.
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sites nor Kd values differed from those of normal en-
docardium. In nine endocardial infarct zones, (- j-iso-
proterenol-stimulated adenylate cyclase activity was re-
duced compared with control (34,870 ± 29,430 versus
88,660 ± 63,640 pmol/mg DNA/30 minutes, p < 0.01),
but the ratio of ( - j-isoproterenol-stimulated to maximal
(sodium fluoride-stimulated) adenylate cyclase activity
was unchanged between normal and infarct zones. No
other changes from normal were found in any of the
other zones. Three weeks after circumflex artery liga-
tion, there were no significant differences in beta-ad-
renergic receptor density or affinity or in (- )-isopro-
terenol-stimulated or maximal adenylate cyclase activity
when normal and infarct zones were compared.
It is concluded that after chronic canine myocardial
infarction there is no evidence of increased beta-adre-
nergic receptor density or augmented ( - )-isoproterenol-
stimulated adenylate cyclase activity. Therefore, any al-
terations in beta-adrenergic receptor properties after
myocardial infarction must occur rapidly or be mediated
by a pathway other than direct alteration of the beta-
adrenergic receptor or coupling between the receptor
and adenylate cyclase.
(J Am Coli Cardiol 1986;8:349-56)
Proposed mechanisms include suppression of arrhythmias
or ischemia produced by augmented catecholamine levels,
reduction in myocardial oxygen requirements or favorable
effects on myocardial blood flow distribution or metabolism
(3-5). Virtually all previous experimental studies of beta-
adrenergic receptor properties in ischemia have been acute
(l to 3 hours) (6-8) or subacute (3 days) (9). Therefore we
decided to measure myocardial blood flow, beta I-adrenergic
receptor density and affinity and adenylate cyclase activity
late (3 weeks) after acute canine myocardial infarction.
The goal of this study was to determine whether there
are long-term alterations in beta-adrenergic receptor density
or adenylate cyclase activity, or both, after myocardial in-
farction. If either an increase in signal transduction mani-
fested as increased enzyme activity or alterations in receptor
0735-1097/86/$3.50
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Figure 1. Myocardial samples and zones. A, Left ventricle. a and
Co Cross sections of myocardium removed for beta-adrenergic re-
ceptor studies and adenylate cyclase assay (four dogs). b, Cross
section of myocardium removed for myocardial blood flow deter-
mination (four dogs). B, Large cross section of myocardium re-
moved for determination of myocardial blood flow 0 beta-adrener-
gic receptor studies and adenylate cyclase assays (five dogs). C,
Cross section of myocardium depicting the zones of myocardium
that were analyzed. See text for details.
the hearts in the first four dogs. This large section was
divided into the previously described four quadrants and
then into endocardial and epicardial regions. After these
fractions were minced with scissors, aliquots were taken
from each tissue sample, weighed and randomly assigned
for measurement of myocardial blood flow, beta-adrenergic
receptor binding studies and assay of adenylate cyclase ac-
tivity.
Preparation of myocardial samples. For the latter anal-
yses, the minced tissue samples from endocardial and epi-
cardial areas and from each of the zones described were
homogenized in 0.25 M sucrose, I J,LM ethylenediamine-
tetraacetic acid and 5 mM Tris-hydrochloride (pH 7.4) and
centrifuged at 270g for 15 minutes. The supernatant was
then pelleted at 4I,300g for 15 minutes and washed two
additional times in the same buffer and frozen in liquid
nitrogen. The samples were stored at -70°C until analysis
several weeks later. Preliminary studies showed that there
is no loss of either receptor binding or adenylate cyclase
activity under these circumstances, compared with fresh
tissue.
Myocardial blood flow measurement. For each mea-
surement of myocardial blood flow, radioactive micro-
spheres (average mean diameter [± SD] 15 ± 2 J,Lm) were
labeled with gadolinium-I53, cobalt-57, chromium-51, tin-
113, strontium-85, niobium-95, indium-I 14 or zinc-65. Us-
ing the reference sample technique (10), I to 2 million
microspheres were injected into the left atrium after thor-
ough agitation. Reference sample collection from a distal
aortic catheter was begun 5 seconds before injection and
continued for 2 minutes, using a Holter pump at a constant
withdrawal rate of IS mllmin. Injection of microspheres had
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density could be demonstrated, an additional rationale would
be provided for the use of long-term beta-adrenergic block-
ade after myocardial infarction.
Experimental preparation. Seventeen mongrel dogs
weighing 20 to 25 kg were studied. Eight of them died
suddenly in the immediate postoperative period. Of the nine
that survived, five underwent ligation of the left anterior
descending coronary artery to produce an anterior wall myo-
cardial infarction and four underwent ligation of the cir-
cumflex coronary artery to produce a posterior wall infarc-
tion. These nine dogs all survived for 3 weeks, after which
they were killed and the heart removed for study.
At the start of the study, each dog underwent a left tho-
racotomy under 1% halothane general anesthesia, and the
coronary arteries and left atrium were exposed through a
small pericardial incision. After control microsphere mea-
surement of myocardial blood flow, either the left anterior
descending (n = 5) or the circumflex (n = 4) coronary
artery was ligated to produce a large acute myocardial in-
farction, and the thoracotomy incision was closed. At the
time of ligation, lidocaine (1 to 2 mg, intravenously) was
given and each day for 1 week postoperatively, procain-
amide (25 mg/kg body weight intramuscularly) was admin-
istered to reduce the incidence of ventricular arrhythmias.
Three weeks after the initial ligation, each of the nine sur-
viving dogs again underwent a left thoracotomy under halo-
thane anesthesia. After repeat measurement of blood flow,
the heart was immediately removed and placed in iced
50 mM Tris buffer, pH 7.4, before sectioning.
Preparation of myocardial zones. In the first four dogs,
the left ventricular free wall and septum were immediately
cut, parallel to the atrioventricular groove, into a large cen-
tral portion and smaller apical and basal rings. The central
portion, which encompassed the infarct area, was subdi-
vided into three rings of equal thickness (Fig. 1). Each
circular section was then divided into four quadrants: infarct,
adjacent medial and lateral zones and a normal zone opposite
to the area of the infarct. Care was taken during sectioning
to avoid contamination of the infarct zone with adjacent
normal-appearing tissue. Each zone was then subdivided
into endocardial and epicardial regions, weighed and minced
with scissors. Apical and basal cross sections were utilized
for measurement of adenylate cyclase activity and for beta-
adrenergic receptor binding studies, and the intervening cen-
ter section was used for coronary blood flow measurement
(Fig. 1).
In the remaining five dogs, including all four dogs with
circumflex coronary artery ligation, a large cross section of
the left ventricle and septum was removed. This cross sec-
tion encompassed the epicardial extent of the infarct and
was equivalent to the basal, central and apical sections of
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Figure 2. Myocardial blood flow in six dogs determined by the
microsphere technique. The persistenceof bloodflow in the infarct
area is presumably due to collateral flow. Shaded bars = control
baseline; crosshatched and hatched bars = infarctarea; vertical
T bars = I SO. *p < 0.005 versuscontrol baseline; **p < 0.02
versuscontrol baseline. ENOO = endocardial; EPI = epicardial;
n = numberof dogs; SO = standarddeviation.
in the control area or in the areas destined to undergo myo-
cardial infarction (infarct baseline). Three weeks after li-
gation the infarct areas showed a marked decline in myo-
cardial blood.flow compared with flow in the opposite control
wall (Fig. 2) . There were no differences between infarct
zones produced by left anterior descending or circumflex
artery ligation.
Radioligand binding studies (Table I). Beta-adrener-
gic receptor density and affinity were measured in eight
endocardial samples and in six epicardial samples from five
dogs that had undergone left anterior descending artery li-
gation . The equilibrium dissociation constant (Kd ) of the
receptors for the radioligand is the amount of radioligand
required to bind to half the receptors. It is measured in units
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Results
Myocardial blood flow studies. Adequate estimates of
myocardial blood flow were obtained in six dogs (two with
left anterior descending and four with circumflex artery li-
gation) . In the preligation studies there were no significant
differences between endocardial and epicardial flows, either
no effect on heart rate or mean aortic pressure in any dog.
A least squares radionuclide separation technique was used
for determination of regional myocardial blood flow (11).
Under these circumstances, there is minimal short- and long-
term loss of microspheres from canine left ventricular myo-
cardium (12).
Radioligand binding studies and adenylate cyclase ac-
tivity. For betaj-adrenergic receptor analyses after left an-
terior descending artery ligation, P2sI]iodocyanopindolol was
used (13), and membrane preparations obtained after cir-
cumflex artery ligation were incubated with [3H]dihy-
droalprenolol, as previously described (14). Nonspecific
binding was defined as that component of total binding not
inhibited by I pM ( - )-propranolol, and it did not exceed
20% of total binding for both radioligands.
All radioligand binding studies were carried out in trip-
licate . Analysis of saturation binding isotherms was per-
formed according to the method of Scatchard (15). Protein
was determined by the method of Lowry et al. (16) , using
bovine serum albumin as standard, and deoxyribonucleic
acid (DNA) content was measured by the method of Hi-
negardner (17). Adenylate cyclase activity was determined
by the method of Salomon et al. (18) . Maximal adenylate
cyclase activity was assessed by measuring cyclic adenosine
monophosphate production in the presence of 10 mM so-
dium fluoride and 0.1 mM guanyl-5 ' -y I imidodiphosphate.
Statistical analysis. All data are expressed as mean ±
SD. For comparisons, Student's t test for paired or unpaired
data was utilized, as appropriate .
Table I. Radioligand Binding Studies
Brnax (frnol/mg DNA)
n Normal Infarct Normal
Left Anterior Descending Artery Ligation
Endocardium 8 9.7 ± 9.4 3.9 ± 1.9* 338 ± 219 pM
Epicardium 6 13.8 ± 13.7 7.2 ± 5.9* 326 ± 163 pM
Circumflex Artery Ligation
Endocardium 4 7.5 ± 3.3 15.3 ± 12.7 5.2 ± 1.6 nM
Epicardium 4 14.8 ± 6.7 11.0 ± 3.1 7.5 ± 4.7 nM
Infarct
304 ± 222 pM
386 ± 269 pM
7.3 ± 3.9 nM
6.1 ± 2.0 nM
*p < 0.05 versus normal myocardium. All data are mean values ± I SO. Bmax = maximal number of
binding sites; DNA = deoxyribonucleic acid; fmol = femtomolcs; K, = equilibrium binding dissociation
constant; n = number of samples.
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were no significant differences in either the endocardial or
the epicardial zone. Thus the reduction in the net ( -)-
isoproterenol-stimulated activity seems to be a consequence
of an overall decline in the endocardial activity of the en-
zyme in the infarct zone .
Figure 3. Adenylatecyclaseactivitystimulatedby sodiumfluoride
and guanyl-5'-yl imidodiphosphate [Gpp(NH)p] after left anterior
descending artery ligation. DNA = deoxyribonucleic acid; n =
number of samples analyzed from five dogs; NaF = sodium fluo-
ride; SD = standard deviation. Shaded bars = normal area;
hatched bars = infarctarea; vertical T bars = I SD. *p < 0.0125;
**p < 0.025; *** p < 0.05.
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Figure 4. Left , Net ( - )-isoproterenol (lSO)-stimulatedadenylate
cyclase activity calculated as [Gpp(NH)p + ISO]- [Gpp(NH)p]
after left anterior descending artery ligation. Right. Ratio of max-
imal (sodium fluoride-stimulated) to net ( - )-isoproterenol (lSO)-
stimulatedadenylatecyclaseactivity. Shaded bars = normalarea;
hatched bars = infarct area; vertical T bars = I SD.
*p < 0.01. Abbreviations as in Figures 2 and 3.
[Gpp (NH) P+ ISO] NaF/lSO
- [GPP(NH)P]
ENDO EPI
of concentration and is inversely related to the affinity or
••strength " with which the receptor binds to the ligand ; that
is, high affinity = low K, and vice versa (19) . There was
no difference in K, values between endocardium and epi-
cardium or between normal and infarct zones. However,
after chronic myocardial infarction there was a decline in
beta-adrenergic receptor density in the infarct zone when
data were expressed per milligram deoxyribonucleic acid
(DNA) content. When protein determinations were utilized
to normalize the data, there was also a decrease in beta ,-
adrenergic receptor density in the infarct zone, but this value
did not achieve statistical significance. Septal and lateral
areas showed no difference either in K, or in the maximal
number of binding sites compared with the normal areas ,
regardless of the method of normalization (n = 6, data not
shown). Similarly, for circumflex artery ligation K, values
showed no differences between endocardium and epicar-
dium or between normal and infarct areas. Also there were
no significant differences in the maximal number of binding
sites , whether normalized per milligram DNA or per mil-
ligram protein.
Adenylate cyclase activity. After left anterior descend-
ing artery ligation, the reduction in beta-adrenergic receptor
density was accompanied by a decline in maximally stim-
ulated adenylate cyclase activity as shown by the 45% re-
duction in enzyme activity after incubation with sodium
fluoride. Similarly, activity stimulated by the nonhydrolyz-
able analog of guanosine triphosphate, guanyl-5'-yl imi-
dodiphosphate, was reduced by 37% in the endocardial layer
when infarcted and normal tissue were compared (Fig . 3) .
In the epicardium maximal enzyme activity was also reduced
by 29% ; guanyl-5' -yl imidodiphosphate-stirnulated activity
was also reduced, but this reduction was not statistically
significant (Fig . 3). These results and the results described
later were similar whether the data were normalized per
milligram DNA or per milligram protein.
Figure 4 depicts the adenylate cyclase activity stimulated
by (- )-isoproterenol after left anterior descending artery
ligation. Because canine myocardial membranes respond
poorly to (- )-isoproterenol stimulation alone at I t-tM , we
measured what we have called net ( - )-isoproterenol stim-
ulation by subtracting the guanyl-5'-yl imidodiphosphate-
stimulated activity from a combination of the latter plus
I t-tM ( - )-isoproterenol-stimulated activity. This is similar
to the approach used by Marsh et al. (20) in chick ventricular
myocardial tissue. As Figure 4 demonstrates, along with
the previously noted reduction in beta-adrenergic receptor
density and sodium fluoride-stimulated adenylate cyclase
activity , there was a significant 61% reduction in net ( - )-
isoproterenol-stimulated aden ylate cycla se activity in the
infarct area in the endocardial zone. There was , however,
no significant difference in the epicardium. When the ratios
of sodium fluoride-stimulated activity to net (- )-isopro-
terenol-stimulated activity were compared, however, there
JACC Vol. 8, No, 2
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the epicardial or endocardial septal or lateral zones (n = 8,
data not shown).
Figure 5. Adenylatecyclaseactivitystimulatedby sodiumfluoride
(NaF) and guanyl-5'-yl imidodiphosphate [Gpp(NH)p] after cir-
cumflex artery ligation in four dogs. Other abbreviations as in
Figure 3. Shaded bars = normal area; hatched bars = infarct
area; vertical T bars = 1 SD. P < 0.05.
Figure 6. Left, Net ( - )-isoproterenol (lSO)-stimulated adenylate
cyclase activity calculated as [Gpp(NH)p + ISO]- [Gpp(NH)p]
after circumflex artery ligation. Right, Ratio of maximal (sodium
fluoride-stimulated) to net (- )-isoproterenol (iSO)-stimulated
adenylate cyclase activity. Abbreviations as in Figures 2 and 3.
Shaded bars = normal area; hatched bars = infarct area; ver-
tical Tbars == I SD. *p < 0.05.
After circumflex coronary artery ligation, there was a
44% increase in sodium fluoride-stimulated adenylate cy-
clase activity in the endocardial zone and no difference in
the epicardium (Fig. 5). The changes in guanyl-S'<yl imi-
dodiphosphate-stimulated adenylate cyclase activity in both
the endocardium and the epicardium were not different. Net
( - )-isoproterenol-stimulated activity in the infarct zone,
whether measured in the endocardium or epicardium, was
not different from that in control areas (Fig. 6). Indeed, the
ratio of sodium fluoride-stimulated to net ( - )-isoproterenol-
stimulated activity increased somewhat in the infarct zone
compared with the normal zone, indicating a relative decline
in catecholamine responsiveness, whereas in the epicardium
there was no significant difference in this ratio.
Adenylate cyclase activity stimulated by sodium fluoride,
guanyl-S'-yl imidodiphosphate and net (- )-isoproterenol-
stimulated activity was not different from control areas in
Discussion
Clinical experience. Two large clinical trials (1,2) in
human subjects have suggested that beta-adrenergic block-
ade begun S to 7 days after acute myocardial infarction may
be useful in preventing recurrent infarction and sudden death.
The results of other clinical trials (21-24) involving smaller
numbers of patients have also supported the use of beta-
blockade after myocardial infarction. However, there has
been some dispute regarding the routine use of beta blockers
after myocardial infarction, particularly in patients who have
had an uncomplicated course (2S). Indeed the results of the
Beta-Blocker Heart Attack Trial demonstrated that the major
benefit occurred in patients who had a complicated course
and that long-term beta-blockade was of relatively little
value in individuals who had an uncomplicated myocardial
infarction or a non-Q wave infarct (2,26).
Mechanism of beta-blockade. The mechanism of action
of beta-blockers in preventing a recurrent infarction or sud-
den death is unknown. After I hour of acute myocardial
ischemia in a canine model, there was an increase in beta-
adrenergic receptor density without a change in affinity, and
after IS minutes of reperfusion there was an increase in
adenylate cyclase activity stimulated by isoproterenol (6,7).
The increase in beta-adrenergic receptor density appears to
result largely from an increase in beta-receptors on cardiac
myocytes rather than on blood vessels (8). Other studies in
the rat (9) have suggested a reduction in beta-receptor den-
sity and adenylate cyclase response in normal myocardium
3 days after myocardial infarction, and in studies in the cat
(27,28) a reduction in catecholamine stores and in contrac-
tile activity occurs in noninfarcted areas; these reductions
return to normal levels 6 weeks after infarction. However,
to our knowledge, no previous investigations have addressed
the issue of whether there are alterations in beta-adrenergic
receptor properties or signal transduction after chronic myo-
cardial infarction. Also, in previous short-term studies, en-
docardial versus epicardial changes were not considered,
nor was myocardial blood flow measured.
Decreased adenylate cyclase activity and beta-receptor
density. We hypothesized that if beta-adrenergic blockade
is useful after chronic myocardial infarction, one mechanism
of action might be that it reduces augmented adenylate cy-
clase activity, possibly as a result of an increased number
of beta-adrenergic receptors in the infarct area or in the peri-
infarction zone. The results of our study indicate that neither
in the infarct zone itself nor in the myocardium immediately
adjacent to the infarct area is there an increase in beta-
receptor density or isoproterenol-stimulated adenylate cy-
clase activity. Indeed, after left anterior descending artery
ligation there appeared to be a reduction in beta-adrenergic
EPI
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receptor density in the infarct zone, accompanied by a gen-
eral reduction in adenylate cyclase activity in this area. Our
data suggest that the reduction in the net ( - I-isoproterenol-
stimulated activity is a result of this overall decline in en-
zyme activity. Such a selective reduction of enzyme activity,
however, does not imply a lack of response to catechol-
amines in areas of depressed myocardium adjacent to the
infarct zone (29,30). Our observation that adenylate cyclase
activity and beta-adrenergic receptor density were normal
in the septal and lateral zones is consistent with both ex-
perimental and clinical observations regarding the normal
perfusion (29) and potential for augmented contractility (30)
of these zones.
Similar changes were not demonstrable after myocardial
infarction produced by circumflex coronary artery ligation,
where beta-receptor density and adenylate cyclase responses
were largely unchanged compared with findings in the op-
posite normal anterior wall. Whether these differences can
be accounted for, at least in part, by regional differences in
beta-adrenergic receptor density in the canine myocardium
is unknown (31). These differences are unlikely to be due
to the different tissue sampling techniques used, because
the reduction in myocardial blood flow, beta-adrenergic re-
ceptor density and adenylate cyclase activity were similar
in the dogs with left anterior descending artery ligation
regardless of the method used to obtain the tissue.
Study limitations. Our study has certain limitations.
Arrhythmias triggering sudden death after chronic myo-
cardial infarction could still occur in a small border zone
surrounding the infarct area (21,32,33). The technique we
used to section the myocardium was not designed to identify
such small, abrupt transition areas, which could possibly be
involved in the pathogenesis of fatal arrhythmias in human
subjects. The decreased coronary blood flow we measured
is reported per gram wet weight of tissue, so that the actual
flow to peninsulas of myocardium could have been normal.
However, the decreased beta-adrenergic receptor density
and diminished adenylate cyclase activity, particularly in
the infarct area produced by left anterior descending liga-
tion, suggest an abnormality of adrenergic function that
could be the result of diminished collateral blood flow to
that area (34). Although dogs have more normally occurring
collateral flow and a greater increase in collateral flow after
coronary occlusion than have humans, in our experiments
the flow to the infarct zone was markedly reduced (Fig. 2).
Such a long-term alteration in perfusion has been described
by Arani et al. (35), who observed reduced coronary blood
flow under rest conditions in collateral-dependent myocar-
dium of patients with complete occlusion of the left anterior
descending coronary artery. In another animal model (36),
chronic hypoxia produced a decrease in both beta-adrenergic
receptor density and adenylate cyclase activity in response
to isoproterenol.
In the Beta-Blocker Heart Attack Trial (2), the major
benefit was in patients with mechanical or electrical com-
plications as opposed to patients with uncomplicated in-
farction. At the time of study, no dog showed evidence of
congestive cardiac failure as manifested by dyspnea, edema,
lethargy or weight loss. No pleural infection or effusions
were noted, and the lungs appeared normal on gross in-
spection. Although each dog studied exhibited substantial
scar formation in the area of the infarct, it is possible that
this experimental model did not produce enough myocardial
damage to cause alterations resembling those that occur in
severe infarction in humans. We recognize that sudden in-
farction produced in a dog by coronary artery ligation may
not mimic the situation that occurs in humans, where chronic
coronary artery obstruction usually precedes infarction.
Nevertheless, 3 weeks after infarction, when we performed
our studies, the hearts exhibited chronic scar formation and
peninsulas of viable myocardium with some residual blood
flow, which to a substantial extent resembles the situation
observed in humans.
Another consideration is the method used to normalize
the data. Histologic sections of the infarct zone showed
areas of normal appearing myocardium surrounded by large
amounts of scar tissue containing scattered fibroblasts which
could have accounted for only small and probably equivalent
amounts of the protein and DNA content of the tissue sam-
pies. The protein assay we employed (16) does not measure
the predominant amino acids in collagen (proline and hy-
droxyproline). In addition, collagen contains no DNA, and
normalization per milligram DNA yielded virtually identical
results to the data normalized per milligram protein, sug-
gesting that for both methods, only viable myocardium in
the infarct zone was being measured.
Possible mechanisms not examined by the present
study. Our results do not exclude the possibility that the
potentially beneficial effects of beta-adrenergic blockade
could be mediated by suppression of acute alterations in the
myocardial response to catecholamine stimulation during
active ischemia (4). Thus, a short-term increase in beta-
adrenergic receptor density (6,37), an augmented adenylate
cyclase response to isoproterenol (7) and the potentially
toxic effects of increased catecholamine release from sym-
pathetic nerve terminals (38) with possible consequent cal-
cium overload (7) could all be prevented by long-term beta-
adrenergic blockade. Other possible mechanisms not ex-
amined in the present study include direct antiarrhythmic
effects (39), reduction in myocardial oxygen requirements
and favorable redistribution of myocardial blood flow during
acute ischemia (3,5).
Conclusions. Nevertheless, our study shows that after
chronic canine myocardial infarction there is no evidence
of increased beta-adrenergic receptor density or augmented
( - j-isoproterenol-stimulated adenyl ate cyclase activity.
Whether the potential utility, if any (25,40), of long-term
beta-adrenergic blockade after uncomplicated myocardial
lACC Vol. 8, No.2
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infarction is mediated by a pathway other than direct alter-
ation of the beta-adrenergic receptor or coupling between
the receptor and adenylate cyclase remains to be demon-
strated. If beta-adrenergic blockade is useful after myo-
cardial infarction, its mechanism of action may possibly be
related to beneficial alterations in the distribution of myo-
cardial blood flow during ischemia rather than to direct
effects on the adrenergic properties of surviving myocar-
dium (41).
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